Vol 2016, No 7 (2016)

Table of Contents

Research & Development

Merck & Co Extend Association with Moderna on New Oncology Programme Abstract pdf html
Keshav Mahawar

Licensing

Novartis bolsters its immuno-oncology pipeline with Xencor’s bispecific antibodies Abstract pdf html
Natasha Berry
Takeda Bolsters Gastrointestinal Franchise with Acquisition of Ex-US Rights to Cx601 Abstract pdf html
Dan Roberts

Mergers & Acquisitions

Struggling Aegerion and QLT Seek Fresh Start via Merger Abstract html pdf
Subham Nandi & Heather Cartwright
BMS Acquires Cormorant to Expand Immuno-oncology Pipeline Abstract pdf html
Jasmine Kalsi
Juno Turns to Immuno-Oncology Combinations with Acquisition of RedoxTherapies Abstract pdf html
Dan Roberts


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.